No response of plasma substance P, but delayed increase of interleukin-1 receptor antagonist to acute psychosocial stress

Life Sciences

Volumn 78, Issue 26, 2006, Pages 3082-3089

  Rohleder, Nicolas ^a   Wolf, Jutta M ^a   Herpfer, Inga ^b   Fiebich, Bernd L ^b   Kirschbaum, Clemens ^a   Lieb, Klaus ^b  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Cortisol; Epinephrine; HPA axis; Human; Inflammation; Interleukin 1ra; Norepinephrine; Psychological stress; Salivary alpha amylase; Substance P

Indexed keywords

ADRENALIN; AMYLASE; HYDROCORTISONE; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; NORADRENALIN; SUBSTANCE P;

ADRENALIN BLOOD LEVEL; ADULT; AMYLASE BLOOD LEVEL; ARTICLE; BLOOD SAMPLING; ENZYME KINETICS; EXERCISE TEST; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IMMUNOASSAY; MALE; MENTAL STRESS; NONHUMAN; NORADRENALIN BLOOD LEVEL; NORMAL HUMAN; RECEPTOR UPREGULATION; REST; SALIVA ANALYSIS; SAMPLE; SOCIAL PROBLEM;

ACUTE DISEASE; ADULT; AFFECT; ALPHA-AMYLASE; AREA UNDER CURVE; BIOLOGICAL MARKERS; ENDOCRINE GLANDS; EPINEPHRINE; HUMANS; HYDROCORTISONE; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; MALE; NOREPINEPHRINE; SALIVA; SIALOGLYCOPROTEINS; SOCIAL ENVIRONMENT; STRESS, PSYCHOLOGICAL; SUBSTANCE P;

EID: 33646174036     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2005.12.016     Document Type: Article

References (48)

1. Arend W.P., Joslin F.G., Thompson R.C., and Hannum C.H. An IL-1 inhibitor from human monocytes. Production and characterization of biologic properties. Journal of Immunology 143 6 (1989) 1851-1858
2. Bargetzi M.J., Lantz M., Smith C.G., Torti F.M., Olsson I., Eisenberg S.P., and Starnes Jr. H.F. Interleukin-1 beta induces interleukin-1 receptor antagonist and tumor necrosis factor binding protein in humans. Cancer Research 53 17 (1993) 4010-4013
3. Bierhaus A., Wolf J., Andrassy M., Rohleder N., Humpert P.M., Petrov D., Ferstl R., Von Eynatten M., Wendt T., Rudofsky G., Joswig M., Morcos M., Schwaninger M., McEwen B., Kirschbaum C., and Nawroth P.P. A mechanism converting psychosocial stress into mononuclear cell activation. Proceedings of the National Academy of Sciences of the United States of America 100 4 (2003) 1920-1925
4. Black P.H. Stress and the inflammatory response: a review of neurogenic inflammation. Brain, Behavior, and Immunity 16 6 (2002) 622-653
5. Caamano J., and Hunter C.A. NF-kappaB family of transcription factors: central regulators of innate and adaptive immune functions. Clinical Microbiology Reviews 15 3 (2002) 414-429
6. Carl V.S., Brown-Steinke K., Nicklin M.J., and Smith Jr. M.F. Toll-like receptor 2 and 4 (TLR2 and TLR4) agonists differentially regulate secretory interleukin-1 receptor antagonist gene expression in macrophages. The Journal of Biological Chemistry 277 20 (2002) 17448-17456
7. Chancellor-Freeland C., Zhu G.F., Kage R., Beller D.I., Leeman S.E., and Black P.H. Substance P and stress-induced changes in macrophages. Annals of the New York Academy of Sciences 771 (1995) 472-484
8. Connolly P.H., Caiozzo V.J., Zaldivar F., Nemet D., Larson J., Hung S.P., Heck J.D., Hatfield G.W., and Cooper D.M. Effects of exercise on gene expression in human peripheral blood mononuclear cells. Journal of Applied Physiology 97 4 (2004) 1461-1469
9. Faulhaber H.D., Oehme P., Baumann R., Enderlein J., Rathsack R., Rostock G., and Naumann E. Substance P in human essential hypertension. Journal of Cardiovascular Pharmacology 10 Suppl 12 (1987) S172-S176
10. Fehder W.P., Sachs J., Uvaydova M., and Douglas S.D. Substance P as an immune modulator of anxiety. Neuroimmunomodulation 4 1 (1997) 42-48
11. Gabay C., Smith M.F., Eidlen D., and Arend W.P. Interleukin 1 receptor antagonist (IL-1Ra) is an acute-phase protein. The Journal of Clinical Investigation 99 12 (1997) 2930-2940
12. Hautzinger M., and Bailer M. Allgemeine Depressionsskala (ADS). Die deutsche Version des CES-D (1992), Beltz, Weinheim
13. Herpfer I., and Lieb K. Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential. CNS Drugs 19 4 (2005) 275-293
14. Kirschbaum C., Pirke K.-M., and Hellhammer D.H. The "Trier Social Stress Test" - a tool for investigating psychobiological stress responses in a laboratory setting. Neuropsychobiology 28 (1993) 76-81
15. Kirschbaum C., Gonzalez Bono E., Rohleder N., Gessner C., Pirke K.M., Salvador A., and Hellhammer D.H. Effects of fasting and glucose load on free cortisol responses to stress and nicotine. Journal of Clinical Endocrinology and Metabolism 82 4 (1997) 1101-1105
16. Kramer M.S., Cutler N., Feighner J., Shrivastava R., Carman J., Sramek J.J., Reines S.A., Liu G., Snavely D., Wyatt-Knowles E., Hale J.J., Mills S.G., MacCoss M., Swain C.J., Harrison T., Hill R.G., Hefti F., Scolnick E.M., Cascieri M.A., Chicchi G.G., Sadowski S., Williams A.R., Hewson L., Smith D., Rupniak N.M., et al. Distinct mechanism for antidepressant activity by blockade of central substance P receptors. Science 281 5383 (1998) 1640-1645
17. Kunz-Ebrecht S.R., Mohamed-Ali V., Feldman P.J., Kirschbaum C., and Steptoe A. Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain, Behavior, and Immunity 17 5 (2003) 373-383
18. Lieb K., Fiebich B.L., Busse-Grawitz M., Hull M., Berger M., and Bauer J. Effects of substance P and selected other neuropeptides on the synthesis of interleukin-1 beta and interleukin-6 in human monocytes: a re-examination. Journal of Neuroimmunology 67 2 (1996) 77-81
19. Lieb K., Fiebich B.L., Berger M., Bauer J., and Schulze-Osthoff K. The neuropeptide substance P activates transcription factor NF-kappa B and kappa B-dependent gene expression in human astrocytoma cells. The Journal of Immunology 159 10 (1997) 4952-4958
20. Lieb K., Schaller H., Bauer J., Berger M., Schulze-Osthoff K., and Fiebich B.L. Substance P and histamine induce interleukin-6 expression in human astrocytoma cells by a mechanism involving protein kinase C and nuclear factor-IL-6. Journal of Neurochemistry 70 4 (1998) 1577-1583
21. Lotz M., Vaughan J.H., and Carson D.A. Effect of neuropeptides on production of inflammatory cytokines by human monocytes. Science 241 4870 (1988) 1218-1221
22. McEwen B.S., and Stellar E. Stress and the individual. Mechanisms leading to disease. Archives of Internal Medicine 153 (1993) 2093-2101
23. Nater U.M., La Marca R., Florin L., Moses A., Langhans W., Koller M.M., and Ehlert U. Stress-induced changes in human salivary alpha-amylase activity-associations with adrenergic activity. Psychoneuroendocrinology ePub ahead of Print (2005)
24. Otsuka M., and Yoshioka K. Neurotransmitter functions of mammalian tachykinins. Physiological Reviews 73 2 (1993) 229-308
25. Pioro E. Distribution of substance P and enkephalin immunoreactive neurons and fibers. In: Paxinos X. (Ed). The Human Nervous System (1990), Academic Press, New York 1051-1094
26. Pruessner J.C., Kirschbaum C., Meinlschmid G., and Hellhammer D.H. Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change. Psychoneuroendocrinology 28 7 (2003) 916-931
27. Re F., Mengozzi M., Muzio M., Dinarello C.A., Mantovani A., and Colotta F. Expression of interleukin-1 receptor antagonist (IL-1ra) by human circulating polymorphonuclear cells. European Journal of Immunology 23 2 (1993) 570-573
28. Rohleder N., Nater U.M., Wolf J.M., Ehlert U., and Kirschbaum C. Psychosocial stress-induced activation of salivary alpha-amylase: an indicator of sympathetic activity?. Annals of the New York Academy of Sciences 1032 (2004) 258-263
29. Sapolsky R.M., Romero L.M., and Munck A.U. How do glucocorticoids influence stress responses? Integrating permissive, suppressive, stimulatory, and preparative actions. Endocrine Reviews 21 1 (2000) 55-89
30. Sauer J., Castren M., Hopfner U., Holsboer F., Stalla G.K., and Arzt E. Inhibition of lipopolysaccharide-induced monocyte interleukin-1 receptor antagonist synthesis by cortisol: involvement of the mineralocorticoid receptor. Journal of Clinical Endocrinology and Metabolism 81 (1996) 73-79
31. Schedlowski M., Fluge T., Richter S., Tewes U., Schmidt R.E., and Wagner T.O. Beta-endorphin, but not substance-P, is increased by acute stress in humans. Psychoneuroendocrinology 20 1 (1995) 103-110
32. Schommer N.C., Hellhammer D.H., and Kirschbaum C. Dissociation between reactivity of the hypothalamus-pituitary-adrenal axis and the sympathetic-adrenal-medullary system to repeated psychosocial stress. Psychosomatic Medicine 65 3 (2003) 450-460
33. Schulz P., and Schlotz W. Trierer Inventar zur Erfassung von chronischem Stress: Skalenkonstruktion, teststatistische Überprüfung und Validierung der Skala Arbeitsüberlastung. Diagnostica 45 1 (1999) 8-19
34. Schulz P., Jansen L.J., and Schlotz W. Stressreaktivität: theoretisches konzept und messung. Diagnostica 51 3 (2005) 124-133
35. Smith Jr. M.F., Carl V.S., Lodie T., and Fenton M.J. Secretory interleukin-1 receptor antagonist gene expression requires both a PU.1 and a novel composite NF-kappaB/PU.1/ GA-binding protein binding site. The Journal of Biological Chemistry 273 37 (1998) 24272-24279
36. Sondergaard S.R., Ostrowski K., Ullum H., and Pedersen B.K. Changes in plasma concentrations of interleukin-6 and interleukin-1 receptor antagonists in response to adrenaline infusion in humans. European Journal of Applied Physiology 83 1 (2000) 95-98
37. Steensberg A., Fischer C.P., Keller C., Moller K., and Pedersen B.K. IL-6 enhances plasma IL-1ra, IL-10, and cortisol in humans. American Journal of Physiology: Endocrinology and Metabolism 285 2 (2003) E433-E437
38. Steptoe A., Owen N., Kunz-Ebrecht S., and Mohamed-Ali V. Inflammatory cytokines, socioeconomic status, and acute stress responsivity. Brain, Behavior, and Immunity 16 6 (2002) 774-784
39. Steptoe A., Willemsen G., Owen N., Flower L., and Mohamed-Ali V. Acute mental stress elicits delayed increases in circulating inflammatory cytokine levels. Clinical Science (London, England: 1979) 101 2 (2001) 185-192
40. Steyer R., Schwenkmezger P., Notz P., and Eid M. Theoretical analyses of the multidimensional mood questionnaire (MDBF). Diagnostica 40 (1994) 320-328
41. Suzuki E., Shintani F., Kanba S., Asai M., and Nakaki T. Immobilization stress increases mRNA levels of interleukin-1 receptor antagonist in various rat brain regions. Cellular and Molecular Neurobiology 17 5 (1997) 557-562
42. Suzuki K., Yamada M., Kurakake S., Okamura N., Yamaya K., Liu Q., Kudoh S., Kowatari K., Nakaji S., and Sugawara K. Circulating cytokines and hormones with immunosuppressive but neutrophil-priming potentials rise after endurance exercise in humans. European Journal of Applied Physiology 81 4 (2000) 281-287
43. Tilg H., Trehu E., Atkins M.B., Dinarello C.A., and Mier J.W. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 83 1 (1994) 113-118
44. Uchakin P.N., Tobin B., Cubbage M., Marshall Jr. G., and Sams C. Immune responsiveness following academic stress in first-year medical students. Journal of Interferon and Cytokine Research 21 9 (2001) 687-694
45. van Stegeren A., Rohleder N., Everaerd W., and Wolf O.T. Salivary alpha amylase as marker for adrenergic activity during stress: effect of betablockade. Psychoneuroendocrinology 31 1 (2006) 137-141
46. Vaupel R., Jarry H., Schlomer H.T., and Wuttke W. Differential response of substance P-containing subtypes of adrenomedullary cells to different stressors. Endocrinology 123 4 (1988) 2140-2145
47. Waschul B., Herforth A., Stiller-Winkler R., Idel H., Granrath N., and Deinzer R. Effects of plaque, psychological stress and gender on crevicular Il-1beta and Il-1ra secretion. Journal of Clinical Periodontology 30 3 (2003) 238-248
48. Weiss D.W., Hirt R., Tarcic N., Berzon Y., Ben-Zur H., Breznitz S., Glaser B., Grover N.B., Baras M., and O'Dorisio T.M. Studies in psychoneuroimmunology: psychological, immunological, and neuroendocrinological parameters in Israeli civilians during and after a period of Scud missile attacks. Behavioral Medicine (Washington, D.C.) 22 1 (1996) 5-14